SIMPLEX TRADING, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is and the CUSIP is 427746902. A total of 3 filers reported holding HERON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$402
+6600.0%
391,000
+8786.4%
0.00%
Q1 2023$6
-57.1%
4,400
-25.4%
0.00%
Q4 2022$14
-99.9%
5,900
+11.3%
0.00%
Q3 2022$22,000
-4.3%
5,300
-36.9%
0.00%
Q2 2022$23,000
-93.3%
8,400
-86.0%
0.00%
Q1 2022$343,000
+453.2%
60,000
+769.6%
0.00%
Q4 2021$62,000
-88.9%
6,900
-81.5%
0.00%
-100.0%
Q3 2021$558,000
-5.3%
37,200
-2.1%
0.00%0.0%
Q2 2021$589,000
+3000.0%
38,000
+316566.7%
0.00%
Q1 2021$19,00012
-91.1%
0.00%
Q4 2020$0
-100.0%
135
-26.6%
0.00%
Q3 2020$272,000
-29.0%
184
-29.5%
0.00%
-100.0%
Q2 2020$383,000
-64.9%
261
-72.0%
0.00%
-50.0%
Q1 2020$1,092,000
+574.1%
931
+1249.3%
0.00%
Q4 2019$162,000
+1.9%
69
-19.8%
0.00%
Q3 2019$159,000
+109.2%
86
+109.8%
0.00%
Q2 2019$76,000
-88.3%
41
-84.5%
0.00%
-100.0%
Q1 2019$647,000
+163.0%
265
+178.9%
0.00%
+100.0%
Q4 2018$246,000
-20.6%
95
-3.1%
0.00%0.0%
Q3 2018$310,000
-88.8%
98
-86.2%
0.00%
-90.9%
Q2 2018$2,758,000
+2865.6%
710
+305.7%
0.01%
+175.0%
Q1 2018$93,000
+6.9%
175
-63.9%
0.00%0.0%
Q4 2017$87,000
+77.6%
485
+43.5%
0.00%
+100.0%
Q3 2017$49,000
+188.2%
338
+199.1%
0.00%
+100.0%
Q2 2017$17,000
+13.3%
113
-5.0%
0.00%0.0%
Q1 2017$15,000
+50.0%
119
-1.7%
0.00%0.0%
Q4 2016$10,000
-23.1%
121
-21.4%
0.00%0.0%
Q3 2016$13,000
+333.3%
154
+250.0%
0.00%
Q2 2016$3,000
-93.2%
44
-86.5%
0.00%
-100.0%
Q1 2016$44,000
+2100.0%
327
+2872.7%
0.00%
Q4 2015$2,000
-91.3%
11
-98.4%
0.00%
-100.0%
Q3 2015$23,000
-89.4%
670
+104.9%
0.00%
-88.9%
Q2 2015$218,000
+4260.0%
327
+341.9%
0.02%
+1700.0%
Q1 2015$5,000740.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 800$1,2080.00%
SIMPLEX TRADING, LLC 4,400$60.00%
View complete list of HERON THERAPEUTICS INC shareholders